John E. Gallina
CIK: 0001433032
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Oct 2, 2026ARAI
Arrive AI Inc.
Award(A)DirectRestricted Stock Award
172.8K shares- - Jul 6, 2026ARAI
Arrive AI Inc.
Award(A)DirectRestricted Stock Award
87.4K shares- - May 14, 2026CVS
CVS HEALTH Corp
Award(A)DirectDeferred Stock Units
1.4K shares at avg. $97.15- - Mar 31, 2026ARAI
Arrive AI Inc.
Award(A)DirectRestricted Stock Award
47.1K shares- - Mar 19, 2026CVS
CVS HEALTH Corp
Award(A)Direct582 shares at avg. $71.86$42K - Dec 31, 2025ARAI
Arrive AI Inc.
Award(A)DirectRestricted Stock Award
14.3K shares- - Oct 6, 2025ARAI
Arrive AI Inc.
Award(A)DirectRestricted Stock Award
7.3K shares- - Oct 6, 2025ARAI
Arrive AI Inc.
Award(A)Direct7.3K shares- - Jun 30, 2025ARAI
Arrive AI Inc.
Award(A)Direct856 shares- - Jun 23, 2025ARAI
Arrive AI Inc.
Award(A)Direct7.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2026 |  ARAI Arrive AI Inc. | Award(A) Restricted Stock Award | 172,811 | - | - | Direct |
| Jul 6, 2026 | ARAI Arrive AI Inc. | Award(A) Restricted Stock Award | 87,413 | - | - | Direct |
| May 14, 2026 |  CVS CVS HEALTH Corp | Award(A) Deferred Stock Units | 1,448 | $97.15 | - | Direct |
| Mar 31, 2026 | ARAI Arrive AI Inc. | Award(A) Restricted Stock Award | 47,052 | - | - | Direct |
| Mar 19, 2026 | CVS CVS HEALTH Corp | Award(A) | 582 | $71.86 | $41,823 | Direct |
| Dec 31, 2025 | ARAI Arrive AI Inc. | Award(A) Restricted Stock Award | 14,259 | - | - | Direct |
| Oct 6, 2025 | ARAI Arrive AI Inc. | Award(A) Restricted Stock Award | 7,292 | - | - | Direct |
| Oct 6, 2025 | ARAI Arrive AI Inc. | Award(A) | 7,292 | - | - | Direct |
| Jun 30, 2025 | ARAI Arrive AI Inc. | Award(A) | 856 | - | - | Direct |
| Jun 23, 2025 | ARAI Arrive AI Inc. | Award(A) | 7,693 | - | - | Direct |
1-10 of 10 transactions
About Gallina John E
Gallina John E (SEC CIK 0001433032) files insider reports with the SEC as Director of Arrive AI Inc. (ARAI) and Director of CVS HEALTH Corp (CVS).
Signal8 holds 11 ownership filings by Gallina John E (2 Form 3, 9 Form 4), filed between Jun 4, 2025 and Oct 9, 2026. Those filings report 10 transactions, from Jun 23, 2025 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gallina John E's filings is in FISHERS, IN.
Recent filings by Gallina John E
- Oct 2, 2026: Grant or award of ARAI derivative securities (Form 4, code A).
- Jul 6, 2026: Grant or award of ARAI derivative securities (Form 4, code A).
- May 14, 2026: Grant or award of CVS derivative securities (Form 4, code A).
- Mar 31, 2026: Grant or award of ARAI derivative securities (Form 4, code A).
- Mar 19, 2026: Grant or award of CVS shares (Form 4, code A).
Other insiders filing for Arrive AI Inc. (ARAI)
- Fitz Michael Todd, Director
- McAdams Kevin Lewis, Director
- Phadke Piyush, CHIEF FINANCIAL OFFICER
- Tucker Laurie Anne, Director
- Shah Neerav Dilip, Chief Strategy Officer
- Hamm Mark David, Chief Operating Officer